FDA Inspection 1034239 — Delpharm Montreal Inc.

Delpharm Montreal Inc. — FEI 3002808099

The FDA completed an inspection of Delpharm Montreal Inc. on Dec 8, 2017 in Pointe-Claire. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 8, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pointe-Claire (Canada)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
111121 CFR 211.25(a)Training , Education , Experience overall
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
122721 CFR 211.67(c)Cleaning/maintenance records not kept
435321 CFR 211.160(b)(4)Instruments, apparatus, et. al. not meeting specs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.